OPKO Health, Inc. Interest Income, Other
OPKO Health, Inc. (OPK) reported Interest Income, Other of $90.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2013-08-09
- OPKO Health, Inc. interest income, other for the quarter ending 2013-06-30 was $90.00K, a 91.49% increase year-over-year.
- OPKO Health, Inc. interest income, other for the quarter ending 2013-03-31 was $59.00K, a 118.52% increase year-over-year.
- OPKO Health, Inc. interest income, other for the quarter ending 2012-12-31 was $65.00K, a 42.48% decline year-over-year.
- OPKO Health, Inc. interest income, other for the quarter ending 2012-09-30 was $49.00K, a 69.18% decline year-over-year.
- OPKO Health, Inc. interest income, other for fiscal 2012 was $188.00K, a 34.72% decline from fiscal 2011.
- OPKO Health, Inc. interest income, other for fiscal 2011 was $288.00K, a 1100.00% increase from fiscal 2010.
- OPKO Health, Inc. interest income, other for fiscal 2010 was $24.00K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2013-06-30 | $90.00K 10-Q · filed 2013-08-09 | $149.00K 10-Q · filed 2013-08-09 | $214.00K derived: sum of 3 quarters · filed 2013-08-09 | $263.00K derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $59.00K 10-Q · filed 2013-05-10 | $124.00K derived: sum of 2 quarters · filed 2013-05-10 | $173.00K derived: sum of 3 quarters · filed 2013-05-10 | $220.00K derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $114.00K derived: sum of 2 quarters · filed 2013-03-18 | $161.00K derived: sum of 3 quarters · filed 2013-08-09 | $188.00K 10-K · filed 2013-03-18 |
| 2012-09-30 | $49.00K 10-Q · filed 2012-11-09 | $96.00K derived: sum of 2 quarters · filed 2013-08-09 | $123.00K 10-Q · filed 2012-11-09 | $236.00K derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $47.00K 10-Q · filed 2013-08-09 | $74.00K 10-Q · filed 2013-08-09 | $187.00K derived: sum of 3 quarters · filed 2013-08-09 | $346.00K derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $27.00K 10-Q · filed 2013-05-10 | $140.00K derived: sum of 2 quarters · filed 2013-05-10 | $299.00K derived: sum of 3 quarters · filed 2013-05-10 | $307.00K derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $272.00K derived: sum of 2 quarters · filed 2013-03-18 | $280.00K derived: sum of 3 quarters · filed 2013-03-18 | $288.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $159.00K 10-Q · filed 2012-11-09 | $167.00K derived: sum of 2 quarters · filed 2012-11-09 | $175.00K 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $8.00K 10-Q · filed 2012-08-09 | $16.00K 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $24.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |